Mucosal Protection
Leyden Labs develops non-vaccine intranasal antibody treatments to protect against respiratory viruses like influenza and coronaviruses.
Genetic medicines
Coave Therapeutics develops genetic medicines using their ALIGATER™ platform to enhance treatment for CNS, neuromuscular, and eye diseases.
Biotechnology
Tasca Therapeutics is a biotechnology company focused on developing small molecule inhibitors for oncology using a unique drug discovery platform.
Neuropsychiatric
Seaport Therapeutics develops neuropsychiatric medicines using its Glyph technology platform to enhance oral bioavailability and reduce side effects, with a focus on treating depression, anxiety, and other disorders.
Biopharmaceutical
City Therapeutics is a biopharmaceutical company focused on developing RNA interference-based medicines using engineered small interfering RNAs to target a broad range of diseases.
Biotech
Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.
Precision Oncology
Engine Biosciences uses machine learning and high-throughput biology to develop precision oncology medicines, and with their recent funding, they plan to advance their biomarker and target discoveries toward the clinic through internal development, collaborations, and partnerships.
Biotech
Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.